Cancer involves a collection of diseases with a common trait–dysregulation in cell
proliferation. At present, traditional therapeutic strategies against cancer have limitations in …

Hypoxia, a quite universal feature in most solid tumors, has been considered as the
“Achilles' heel” of traditional photodynamic therapy (PDT) and substantially impairs the …

Strong oxygen dependence, poor tumor targeting, and limited treatment depth have been
considered as the “Achilles' heels” facing the clinical usage of photodynamic therapy (PDT) …

Recently, photodynamic therapy (PDT) has become a promising approach for the treatment
of a broad range of diseases, including oncological and infectious diseases. This minimally …

Photodynamic diagnosis (PDD) and therapy (PDT) are emerging, non/minimally invasive
techniques for cancer diagnosis and treatment. Both techniques require a photosensitizer …

The dense cancer microenvironment is a significant barrier that limits the penetration of
anticancer agents, thereby restraining the efficacy of molecular and nanoscale cancer …

Bioorthogonal chemistry has been a powerful tool in chemical biology. It can facilitate the
study of biomolecules in their native environments and enables targeted delivery and …

Triple‐negative breast cancer (TNBC) has the worst prognosis among all subtypes of breast
cancer. Currently, no targeted treatment has been approved for TNBC. The goal of this study …

Photodynamic therapy (PDT) is a clinically-approved cancer treatment that is based on
production of cytotoxic reactive oxygen species to induce cell death. However, its efficiency …

Photodynamic therapy (PDT) is a medical radio chemotherapeutic method that uses light,
photosensitizing agents, and oxygen to produce cytotoxic compounds, which eliminate …